As of 2025-10-24, the Relative Valuation of Keros Therapeutics Inc (KROS) is 14.88 USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.88 USD, the upside of Keros Therapeutics Inc based on Relative Valuation is 0.0%.
The range of the Relative Valuation is 14.88 - 14.88 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 32.2x - 32.2x | 32.2x |
| Fair Price | 14.88 - 14.88 | 14.88 |
| Upside | 0.0% - 0.0% | 0.0% |
| Date | P/E |